Compounds > lopinavir
Page last updated: 2024-08-26

lopinavir and zithromax

lopinavir has been researched along with zithromax in 54 studies

Research

Studies (54)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's4 (7.41)24.3611
2020's50 (92.59)2.80

Authors

AuthorsStudies
Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A1
Lopes, F; Moreira, R; Mota, MM; Prudêncio, M; Rodrigues, T1
Afshari, CA; Chen, Y; Dunn, RT; Hamadeh, HK; Kalanzi, J; Kalyanaraman, N; Morgan, RE; van Staden, CJ1
Blaszczyk, AT; Vouri, SM1
Cutrell, JB; Jodlowski, TZ; Monogue, ML; Sanders, JM1
Doan, T; Oldenburg, CE1
Hsueh, PR; Jean, SS; Lee, PI1
Han, S; Hyun, M; Jin, K; Kim, HA; Kim, Y; Kwon, O; Lee, JY; Paek, JH; Park, WY1
Adebayo, AI; Adeoye, AO; Olaoye, IF; Oso, BJ; Tijjani, H1
Carretero-Barrio, I; Fernandez-Nieto, D; Jimenez-Cauhe, J; Moreno-Garcia Del Real, C; Ortega-Quijano, D; Saceda-Corralo, D; Suarez-Valle, A1
Anselmi, E; Cavanna, L; Citterio, C; Codeluppi, M; Stroppa, EM; Toscani, I; Zaffignani, E1
Aggarwal, G; Aggarwal, S; Bangalore, S; Henry, BM1
Alffenaar, JW; Andréjak, C; Bachez, P; Bart, PA; Belilovski, E; Blanc, FX; Borisov, S; Cardoso-Landivar, J; Centis, R; Codecasa, LR; D'Ambrosio, L; Dominguez-Castellano, A; Dourmane, S; Fréchet Jachym, M; Froissart, A; García-García, JM; Giacomet, V; Goletti, D; Grard, S; Gualano, G; Izadifar, A; Le Du, D; Luiza De Souza-Galvão, M; Marín Royo, M; Mazza-Stalder, J; Migliori, GB; Motta, I; Ong, CWM; Palmieri, F; Rivière, F; Rodrigo, T; Sánchez-Montalvá, A; Saporiti, M; Scarpellini, P; Schlemmer, F; Silva, DR; Sotgiu, G; Spanevello, A; Sumarokova, E; Tabernero, E; Tadolini, M; Tambyah, PA; Tiberi, S; Torre, A; Visca, D; Zabaleta Murguiondo, M1
Campos, L; Gouveia, CC1
Danion, F; Fourtage, M; Greigert, V; Hansmann, Y; Kaeuffer, C; Lefebvre, N; Muller, J; Nai, T; Ruch, Y1
Azadi, H; Darabi, E; Fathi, S; Ghanei, M; Ghazale, AH; Ghazvini, A; Izadi, M; Jafari, R; Movaseghi, F; Mozafari, A; Panahi, Y; Parsaei, MR; Ranjkesh, MH; Rezapour, M; Saadat, SH; Salesi, M; Vahedi, E; Zand, N1
Fueyo-Rodriguez, O; Moreno-Sanchez, F; Palomar-Lever, A; Valente-Acosta, B1
Aguado, P; Balsa, A; Bernad-Pineda, M; Bogas, P; Bonilla, G; Castilla-Plaza, A; De Miguel, E; Franco-Gómez, K; García-Lorenzo, E; Miranda-Carus, ME; Monjo, I; Novella Navarro, M; Nuño, L; Peiteado, D; Rodríguez-Araya, T; Tornero, C; Villalba, A1
Carron, J; Hussein, H; Kennedy, M; McAdam, B; Sharif, Z; Sheahan, R1
Cauda, R; Cingolani, A; Cipriani, MC; Fantoni, M; Gremese, E; Larosa, L; Liperoti, R; Montemurro, G; Murri, R; Pasciuto, G; Pirronti, T; Tummolo, AM1
Argov, Z; Gotkine, M; Haham, N; Orenbuch-Harroch, E; Rein, N; Romain, M; Vaknin-Dembinsky, A1
Barbonetti, A; Berardicurti, A; Berardicurti, O; D'Andrea, S; Felzani, G; Francavilla, F; Francavilla, S; Giacomelli, R1
Barba-Gyengo, N; Cabrero-Rodríguez, C; Fernández-García, MÁ; Gámez-Baeza, P; Gámiz-Molina, AB; García-Martín, M; Guirado-Ruiz, PA; Jiménez-Mejías, E; Láinez-Ramos-Bossini, AJ; Mancera-Romero, J; Martín-delosReyes, LM; Martín-Romero, DT; Martínez-Diz, S; Martínez-Ruiz, V; R-delAmo, JL; Rivera-Izquierdo, M; Rodríguez-Camacho, M; Sánchez-Pérez, MR; Tahery-Mahmoud, A; Valero-Ubierna, MDC1
Álvaro-Gracia, J; Castrejón, I; González, T; Martínez-Barrio, J; Molina Collada, J; Montero, F; Rivera, J; Serrano-Benavente, B1
Ahmadinejad, Z; Ghiasvand, F; Golestan, FS; Hajiabdolbaghi, M; Jafari, F; Jafari, S; Jamalimoghadamsiahkali, S; Khalili, H; Kouchak, HE; Manafi, N; Pirhayati, M; Sadr, S; Salehi, M; Seifi, A; Sekhavati, E; SeyedAlinaghi, S; Tabarestani, M; Zendehdel, A1
Ding, C; García, JA; García-Abellán, J; García-Pachón, E; Guillén, L; Gutiérrez, F; Masiá, M; Mora, A; Padilla, S; Telenti, G1
Amézaga Menéndez, R; Catalán González, M; Díaz, E; Escapa, MG; Marcos Neira, P; Quintana Díaz, M; Serrano Lázaro, A; Suberviola, B; Vidal Cortés, P1
Birlutiu, V; Iancu, GM; Solomon, A1
Antonijević Miljaković, E; Antonijević, B; Baralić, K; Buha Djordjevic, A; Ćurčić, M; Jorgovanović, D; Živančević, K; Đukić-Ćosić, D1
Jones, CW; Platts-Mills, TF; Woodford, AL1
Grundmark, B; Vidlin, SH; Watson, S; Zekarias, A1
Ahuka-Mundeke, S; Bongo-Pasi Nswe, C; Hermans, MP; Ishoso, DK; Kayembe, JM; Kolié, MC; Machekano, RN; Madinga, JN; Mavungu Landu, DJ; Mbala-Kingebeni, P; Mbuyi, GM; Mellors, JW; Mills, EJ; Mofenson, L; Mukeba Tshialala, D; Mukendi, S; Muyembe-Tamfum, JJ; Nachega, JB; Nkwembe, EN; Nsio, JM; Otokoye, JO; Sam-Agudu, NA; Smith, G; Tshiasuma Pipo, M; Zumla, A1
Mamishi, S; Navaeian, A; Shabanian, R1
Akat, H; Laloglu, F; Orbak, Z1
Campana, C; Dariolli, R; Gutierrez, A; Irurzun-Arana, I; Pullinger, TK; Sobie, EA; Varshneya, M1
Belmas, AS; Danion, F; Fourtage, M; Gourieux, B; Michel, B; Nai, T; Nivoix, Y; Reisz, F; Reiter-Schatz, A; Ruch, Y; Walther, J1
Haddad, F; Herth, FJF; Sakoulas, G1
Dingding, Q; Jiangfang, L; Yujia, W; Zequn, Z1
Chen, J; Liu, D; Lu, H; Yin, L; Zhang, L1
Alhashmi, A; Belfaqeeh, O; Janapala, RN; Patel, J; Pourmand, A1
Arouche, TDS; Costa, FLP; Filho, TSA; Júnior, RNC; Martins, AY; Neto, AMJC; Ramalho, TC1
Brügel, M; Habler, K; Liebchen, U; Paal, M; Scharf, C; Schönermarck, U; Teupser, D; Vogeser, M1
Brañez-Condorena, A; Diaz-Arocutipa, C; Hernandez, AV1
Aghajani, F; Akhavizadegan, H; Dolatkhani, F; Faghir Gangi, M; Ghasemi, H; Ghazi, Z; Mousavi Movahed, SM; Nejadghaderi, SA1
Ahmed, WU; Alghoul, H; Alser, O; Alshammari, TM; Areia, C; Burn, E; Carter, W; Casajust, P; Cho, J; Dawoud, D; Duarte-Salles, T; Golozar, A; Gong, M; Hripcsak, G; Jonnagaddala, J; Kostka, K; Lai, LYH; Lane, JC; Liu, L; Lynch, KE; Matheny, ME; Mehta, PP; Morales, DR; Nyberg, F; Posada, JD; Prats-Uribe, A; Prieto-Alhambra, D; Recalde, M; Reich, C; Rijnbeek, PR; Roel, E; Ryan, PB; Schilling, LM; Sena, AG; Shah, K; Shah, NH; Subbian, V; Suchard, MA; Vizcaya, D; You, SC; Zhang, L; Zhang, Y; Zhu, H1
Benito-González, T; Borrego-Rodríguez, J; Del Castillo-García, S; Echarte-Morales, J; Fernández-Vázquez, F; Flores-Vergara, G; García-Bergel, R; Iglesias-Garriz, I; Maniega, CG; Menéndez-Suárez, P; Minguito-Carazo, C; Palacios-Echavarren, C; Prieto-González, S; Rodríguez-Santamarta, M; Sánchez-Muñoz, E1
Arabi, M; Bitar, F; Eid, AH; Fakhri, G; Younis, NK; Zareef, RO1
Alkan, M; Demirkol, MA; Dinc, V; Esatoglu, SN; Kamat, S; Kostek, ME; Sargin Altunok, E; Satici, C; Toprak, ID; Yazla, S1
Airlangga, MP; Fatimah, FN; Miftahussurur, M; Pradana, AD; Rianda, RA; Rianda, RV; Subkhan, M1
Cevenini, F; Fallani, E; Lazzerini, PE; Saponara, S; Verdini, A1
Ioannidis, JPA1
Hong, W; Hwang, TH; Jang, J; Jang, SP; Jang, SW; Kim, BO; Park, HW; Park, SK; Park, YK; Shin, J; Yang, W1

Reviews

10 review(s) available for lopinavir and zithromax

ArticleYear
Targeting the liver stage of malaria parasites: a yet unmet goal.
    Journal of medicinal chemistry, 2012, Feb-09, Volume: 55, Issue:3

    Topics: Animals; Antimalarials; Humans; Life Cycle Stages; Liver; Malaria; Plasmodium; Structure-Activity Relationship

2012
Pharmacologic Treatments for Coronavirus Disease 2019 (COVID-19): A Review.
    JAMA, 2020, May-12, Volume: 323, Issue:18

    Topics: Adenosine Monophosphate; Adrenal Cortex Hormones; Alanine; Amides; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Antiviral Agents; Azithromycin; Betacoronavirus; Chloroquine; Coronavirus Infections; COVID-19; COVID-19 Drug Treatment; Humans; Hydroxychloroquine; Immunoglobulins; Immunologic Factors; Indoles; Lopinavir; Oseltamivir; Pandemics; Pneumonia, Viral; Pyrazines; Ribavirin; Ritonavir; SARS-CoV-2; Withholding Treatment

2020
Treatment options for COVID-19: The reality and challenges.
    Journal of microbiology, immunology, and infection = Wei mian yu gan ran za zhi, 2020, Volume: 53, Issue:3

    Topics: Adenosine Monophosphate; Alanine; Amides; Antiviral Agents; Azithromycin; Betacoronavirus; Coronavirus Infections; COVID-19; COVID-19 Serotherapy; Drug Combinations; Humans; Hydroxychloroquine; Immunization, Passive; Lopinavir; Pandemics; Pneumonia, Viral; Pyrazines; Ritonavir; RNA-Dependent RNA Polymerase; SARS-CoV-2; Teicoplanin

2020
Cardiovascular Safety of Potential Drugs for the Treatment of Coronavirus Disease 2019.
    The American journal of cardiology, 2020, 08-01, Volume: 128

    Topics: Adenosine Monophosphate; Alanine; Anti-Infective Agents; Azithromycin; Betacoronavirus; Cardiovascular Diseases; Coronavirus Infections; COVID-19; COVID-19 Drug Treatment; Drug Combinations; Enzyme Inhibitors; Humans; Hydroxychloroquine; Lopinavir; Pandemics; Pneumonia, Viral; Ritonavir; SARS-CoV-2

2020
Coronavirus Disease 2019: Clinical Review.
    Acta medica portuguesa, 2020, Jul-01, Volume: 33, Issue:7-8

    Topics: Adenosine Monophosphate; Alanine; Amides; Animals; Antiviral Agents; Azithromycin; Betacoronavirus; Blood Coagulation Disorders; China; Chiroptera; Chloroquine; Coronavirus Infections; COVID-19; Glucocorticoids; Humans; Hydroxychloroquine; Infectious Disease Incubation Period; Lopinavir; Lung; Pandemics; Pneumonia, Viral; Prognosis; Pyrazines; Radiography, Thoracic; Reverse Transcriptase Polymerase Chain Reaction; SARS-CoV-2; Symptom Assessment

2020
Clinical guidance for navigating the QTc-prolonging and arrhythmogenic potential of pharmacotherapy during the COVID-19 pandemic.
    Irish journal of medical science, 2021, Volume: 190, Issue:1

    Topics: Anti-Bacterial Agents; Antiviral Agents; Azithromycin; COVID-19 Drug Treatment; Drug Combinations; Electrocardiography; Enzyme Inhibitors; Humans; Hydroxychloroquine; Long QT Syndrome; Lopinavir; Magnesium; Pandemics; Potassium; Practice Guidelines as Topic; Risk Assessment; Risk Factors; Ritonavir; SARS-CoV-2; Torsades de Pointes

2021
[Pharmacological treatment of COVID-19: Narrative review of the Working Group in Infectious Diseases and Sepsis (GTEIS) and the Working Groups in Transfusions and Blood Products (GTTH)].
    Medicina intensiva, 2021, Volume: 45, Issue:2

    Topics: Adenosine Monophosphate; Adrenal Cortex Hormones; Alanine; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Anticoagulants; Antiviral Agents; Azithromycin; COVID-19; COVID-19 Drug Treatment; COVID-19 Serotherapy; Disease Progression; Humans; Hydroxychloroquine; Immunization, Passive; Immunoglobulins, Intravenous; Immunomodulation; Interferon-beta; Interleukin 1 Receptor Antagonist Protein; Lopinavir; Nitriles; Protein Kinase Inhibitors; Pyrazoles; Pyrimidines; Ritonavir; SARS-CoV-2

2021
Off-label use of chloroquine, hydroxychloroquine, azithromycin and lopinavir/ritonavir in COVID-19 risks prolonging the QT interval by targeting the hERG channel.
    European journal of pharmacology, 2021, Feb-15, Volume: 893

    Topics: Azithromycin; Chloroquine; COVID-19; COVID-19 Drug Treatment; Drug Combinations; ERG1 Potassium Channel; Humans; Hydroxychloroquine; Long QT Syndrome; Lopinavir; Off-Label Use; Ritonavir

2021
QTc prolongation in COVID-19 patients treated with hydroxychloroquine, chloroquine, azithromycin, or lopinavir/ritonavir: A systematic review and meta-analysis.
    Pharmacoepidemiology and drug safety, 2021, Volume: 30, Issue:6

    Topics: Azithromycin; Chloroquine; COVID-19; COVID-19 Drug Treatment; Humans; Hydroxychloroquine; Long QT Syndrome; Lopinavir; Observational Studies as Topic; Ritonavir

2021
COVID-19: potential therapeutics for pediatric patients.
    Pharmacological reports : PR, 2021, Volume: 73, Issue:6

    Topics: Adenosine Monophosphate; Alanine; Anti-Inflammatory Agents; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antiviral Agents; Azithromycin; Child; COVID-19 Drug Treatment; Dexamethasone; Humans; Hydroxychloroquine; Ivermectin; Lopinavir; Oseltamivir; SARS-CoV-2; Spike Glycoprotein, Coronavirus

2021

Trials

1 trial(s) available for lopinavir and zithromax

ArticleYear
Safety and effectiveness of azithromycin in patients with COVID-19: An open-label randomised trial.
    International journal of antimicrobial agents, 2020, Volume: 56, Issue:4

    Topics: Adult; Aged; Anti-Infective Agents; Azithromycin; Betacoronavirus; C-Reactive Protein; Coronavirus Infections; COVID-19; Disease Progression; Drug Combinations; Female; Heart Rate; Humans; Hydroxychloroquine; Intensive Care Units; Lopinavir; Male; Middle Aged; Pandemics; Patient Safety; Pneumonia, Viral; Prognosis; Respiratory Function Tests; Ritonavir; SARS-CoV-2; Survival Analysis; T-Lymphocytes; Tomography, X-Ray Computed; Treatment Outcome

2020

Other Studies

43 other study(ies) available for lopinavir and zithromax

ArticleYear
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
    Chemical research in toxicology, 2010, Volume: 23, Issue:1

    Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship

2010
A multifactorial approach to hepatobiliary transporter assessment enables improved therapeutic compound development.
    Toxicological sciences : an official journal of the Society of Toxicology, 2013, Volume: 136, Issue:1

    Topics: Animals; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Transport; Chemical and Drug Induced Liver Injury; Cluster Analysis; Drug-Related Side Effects and Adverse Reactions; Humans; Liver; Male; Multidrug Resistance-Associated Proteins; Pharmacokinetics; Rats; Rats, Sprague-Dawley; Recombinant Proteins; Risk Assessment; Risk Factors; Toxicity Tests

2013
HIV: a growing concern in the elderly population.
    The Consultant pharmacist : the journal of the American Society of Consultant Pharmacists, 2012, Volume: 27, Issue:5

    Topics: Aged; AIDS-Related Opportunistic Infections; Anti-HIV Agents; Antihypertensive Agents; Azithromycin; CD4 Lymphocyte Count; Depressive Disorder; Diltiazem; Drug Interactions; Drug Monitoring; HIV Infections; Humans; Hypertension; Lopinavir; Male; Patient Compliance; Pharmacists; Renal Insufficiency; Trimethoprim, Sulfamethoxazole Drug Combination; Zidovudine

2012
Rigorous Randomized Controlled Trial Implementation in the Era of COVID-19.
    The American journal of tropical medicine and hygiene, 2020, Volume: 102, Issue:6

    Topics: Antiviral Agents; Azithromycin; Betacoronavirus; Clinical Laboratory Techniques; Coronavirus Infections; COVID-19; COVID-19 Testing; Drug Repositioning; Humans; Hydroxychloroquine; Lopinavir; Pandemics; Pneumonia, Viral; Practice Guidelines as Topic; Randomized Controlled Trials as Topic; Ritonavir; Sample Size; SARS-CoV-2; United States

2020
Some drugs for COVID-19.
    The Medical letter on drugs and therapeutics, 2020, 04-06, Volume: 62, Issue:1595

    Topics: Adenosine Monophosphate; Adrenal Cortex Hormones; Alanine; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Anti-Inflammatory Agents, Non-Steroidal; Azithromycin; Betacoronavirus; Chloroquine; Clinical Trials as Topic; Coronavirus Infections; COVID-19; COVID-19 Drug Treatment; COVID-19 Serotherapy; Drug Combinations; Drug Repositioning; Humans; Hydroxychloroquine; Immunization, Passive; Lopinavir; Neuraminidase; Pandemics; Pneumonia, Viral; Ritonavir; SARS-CoV-2

2020
Two distinct cases with COVID-19 in kidney transplant recipients.
    American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons, 2020, Volume: 20, Issue:8

    Topics: Adult; Antiviral Agents; Azithromycin; Betacoronavirus; Calcineurin Inhibitors; Coronavirus Infections; COVID-19; COVID-19 Drug Treatment; Drug Combinations; Drug Interactions; Humans; Hydroxychloroquine; Immunosuppressive Agents; Kidney Failure, Chronic; Kidney Transplantation; Lopinavir; Male; Middle Aged; Pandemics; Pneumonia, Viral; Ritonavir; SARS-CoV-2; Tacrolimus; Transplant Recipients

2020
Repurposing of chloroquine and some clinically approved antiviral drugs as effective therapeutics to prevent cellular entry and replication of coronavirus.
    Journal of biomolecular structure & dynamics, 2021, Volume: 39, Issue:10

    Topics: Adenosine Monophosphate; Alanine; Antiviral Agents; Azithromycin; Chloroquine; Drug Repositioning; Humans; Lopinavir; Molecular Docking Simulation; Severe acute respiratory syndrome-related coronavirus; Virus Internalization; Virus Replication

2021
Erythema multiforme-like eruption in patients with COVID-19 infection: clinical and histological findings.
    Clinical and experimental dermatology, 2020, Volume: 45, Issue:7

    Topics: Adrenal Cortex Hormones; Aged; Anti-Bacterial Agents; Antiviral Agents; Azithromycin; C-Reactive Protein; Ceftriaxone; COVID-19; COVID-19 Drug Treatment; Drug Combinations; Erythema Multiforme; Female; Fibrin Fibrinogen Degradation Products; Hospitalization; Humans; Hydroxychloroquine; Lopinavir; Lymphocyte Count; Middle Aged; Ritonavir

2020
Biggest COVID-19 trial tests repurposed drugs first.
    Nature biotechnology, 2020, Volume: 38, Issue:5

    Topics: Adaptive Clinical Trials as Topic; Azithromycin; Betacoronavirus; Coronavirus Infections; COVID-19; COVID-19 Drug Treatment; Dexamethasone; Drug Combinations; Drug Repositioning; Humans; Hydroxychloroquine; Lopinavir; Pandemics; Pneumonia, Viral; Randomized Controlled Trials as Topic; Ritonavir; SARS-CoV-2; Standard of Care; United Kingdom

2020
Coronavirus disease-2019 in cancer patients. A report of the first 25 cancer patients in a western country (Italy).
    Future oncology (London, England), 2020, Volume: 16, Issue:20

    Topics: Age Factors; Aged; Aged, 80 and over; Antiviral Agents; Azithromycin; Betacoronavirus; Ceftriaxone; Cobicistat; Coronavirus Infections; COVID-19; COVID-19 Drug Treatment; Darunavir; Drug Therapy, Combination; Female; HIV Protease Inhibitors; Humans; Hydroxychloroquine; Italy; Lopinavir; Male; Methylprednisolone; Middle Aged; Neoplasms; Pandemics; Pneumonia, Viral; Ritonavir; SARS-CoV-2

2020
Active tuberculosis, sequelae and COVID-19 co-infection: first cohort of 49 cases.
    The European respiratory journal, 2020, Volume: 56, Issue:1

    Topics: Adult; Aged; Antitubercular Agents; Antiviral Agents; Azithromycin; Betacoronavirus; Clinical Laboratory Techniques; Cohort Studies; Coinfection; Coronavirus Infections; COVID-19; COVID-19 Drug Treatment; COVID-19 Testing; Drug Combinations; Emigrants and Immigrants; Female; Humans; Hydroxychloroquine; Lopinavir; Lung; Male; Middle Aged; Mortality; Pandemics; Pneumonia, Viral; Ritonavir; SARS-CoV-2; Tomography, X-Ray Computed; Tuberculosis; Tuberculosis, Pulmonary

2020
The Good, the Bad, and the Hoax: When Publication Instantaneously Impacts Treatment Strategies for COVID-19.
    Antimicrobial agents and chemotherapy, 2020, 07-22, Volume: 64, Issue:8

    Topics: Antiviral Agents; Azithromycin; Betacoronavirus; Coronavirus Infections; COVID-19; COVID-19 Drug Treatment; Deception; Drug Combinations; France; Humans; Hydroxychloroquine; Lopinavir; Pandemics; Pneumonia, Viral; Ritonavir; SARS-CoV-2; Scholarly Communication

2020
The clinical value of two combination regimens in the Management of Patients Suffering from Covid-19 pneumonia: a single centered, retrospective, observational study.
    Daru : journal of Faculty of Pharmacy, Tehran University of Medical Sciences, 2020, Volume: 28, Issue:2

    Topics: Adult; Aged; Azithromycin; COVID-19; COVID-19 Drug Treatment; Drug Combinations; Drug Therapy, Combination; Female; Hospitalization; Humans; Hydroxychloroquine; Iran; Length of Stay; Levofloxacin; Lopinavir; Male; Meropenem; Middle Aged; Naproxen; Oseltamivir; Pneumonia, Viral; Prednisolone; Retrospective Studies; Ritonavir; Treatment Outcome; Vancomycin

2020
Rhabdomyolysis as an initial presentation in a patient diagnosed with COVID-19.
    BMJ case reports, 2020, Jun-24, Volume: 13, Issue:6

    Topics: Aged; Anti-Bacterial Agents; Antibodies, Monoclonal, Humanized; Anticoagulants; Azithromycin; Betacoronavirus; Bicarbonates; Ceftriaxone; Coronavirus Infections; COVID-19; Cytochrome P-450 CYP3A Inhibitors; Enoxaparin; Enzyme Inhibitors; Fluid Therapy; Humans; Hydroxychloroquine; Lopinavir; Lung; Male; Pandemics; Pneumonia, Viral; Respiration, Artificial; Rhabdomyolysis; Ritonavir; SARS-CoV-2; Tomography, X-Ray Computed; Treatment Outcome

2020
Clinical course, severity and mortality in a cohort of patients with COVID-19 with rheumatic diseases.
    Annals of the rheumatic diseases, 2020, Volume: 79, Issue:12

    Topics: Adult; Aged; Antirheumatic Agents; Antiviral Agents; Arthritis, Psoriatic; Arthritis, Rheumatoid; Azithromycin; Betacoronavirus; Cohort Studies; Coronavirus Infections; COVID-19; COVID-19 Drug Treatment; Drug Combinations; Female; Glucocorticoids; Humans; Hydroxychloroquine; Immunoglobulins, Intravenous; Immunologic Factors; Lopinavir; Lupus Erythematosus, Systemic; Male; Middle Aged; Pandemics; Pneumonia, Viral; Retrospective Studies; Rheumatic Diseases; Ritonavir; SARS-CoV-2; Severity of Illness Index; Spondylarthropathies

2020
Baricitinib as rescue therapy in a patient with COVID-19 with no complete response to sarilumab.
    Infection, 2020, Volume: 48, Issue:5

    Topics: Acute Disease; Aged; Antibodies, Monoclonal, Humanized; Antiviral Agents; Azetidines; Azithromycin; Betacoronavirus; Coronavirus Infections; COVID-19; Drug Combinations; Drug Repositioning; Humans; Hydroxychloroquine; Lopinavir; Male; Pandemics; Pneumonia, Viral; Purines; Pyrazoles; Respiratory Insufficiency; Ritonavir; SARS-CoV-2; Sulfonamides; Treatment Outcome

2020
Description of 3 patients with myasthenia gravis and COVID-19.
    Journal of the neurological sciences, 2020, 10-15, Volume: 417

    Topics: Adult; Aged; Azithromycin; Betacoronavirus; Coronavirus Infections; COVID-19; COVID-19 Drug Treatment; Diabetes Mellitus, Type 2; Female; Humans; Hydroxychloroquine; Hypertension; Hypothyroidism; Immunocompromised Host; Immunoglobulins, Intravenous; Immunosuppressive Agents; Lopinavir; Male; Myasthenia Gravis; Pandemics; Plasmapheresis; Pneumonia, Viral; Ritonavir; SARS-CoV-2; Treatment Outcome

2020
Clinical features and prognosis of COVID-19 in people with spinal cord injury: a case-control study.
    Spinal cord series and cases, 2020, 08-04, Volume: 6, Issue:1

    Topics: Adult; Aged; Anti-Bacterial Agents; Antibodies, Monoclonal, Humanized; Anticoagulants; Antiviral Agents; Azithromycin; Betacoronavirus; Case-Control Studies; Coronavirus Infections; COVID-19; COVID-19 Drug Treatment; Drug Combinations; Enzyme Inhibitors; Female; Heparin, Low-Molecular-Weight; Humans; Hydroxychloroquine; Italy; Lopinavir; Male; Middle Aged; Oxygen Inhalation Therapy; Pandemics; Pneumonia, Viral; Prognosis; Rehabilitation Centers; Ritonavir; SARS-CoV-2; Spinal Cord Injuries

2020
[Therapeutic agents tested in 238 COVID-19 hospitalized patients and their relationship with mortality].
    Medicina clinica, 2020, 11-13, Volume: 155, Issue:9

    Topics: Adrenal Cortex Hormones; Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Antibodies, Monoclonal, Humanized; Antiviral Agents; Azithromycin; Betacoronavirus; Comorbidity; Coronavirus Infections; COVID-19; COVID-19 Drug Treatment; Drug Therapy, Combination; Female; Humans; Hydroxychloroquine; Inpatients; Lopinavir; Male; Pandemics; Pneumonia, Viral; Proportional Hazards Models; Retrospective Studies; Ritonavir; SARS-CoV-2; Spain; Treatment Outcome

2020
Coronavirus disease 2019 (COVID-19) in autoimmune and inflammatory conditions: clinical characteristics of poor outcomes.
    Rheumatology international, 2020, Volume: 40, Issue:10

    Topics: Aged; Anti-Bacterial Agents; Antibodies, Monoclonal, Humanized; Antirheumatic Agents; Antiviral Agents; Arthritis, Psoriatic; Arthritis, Rheumatoid; Autoimmune Diseases; Azithromycin; Betacoronavirus; Comorbidity; Coronavirus Infections; COVID-19; COVID-19 Drug Treatment; Drug Combinations; Female; Glucocorticoids; Hospitalization; Humans; Hydroxychloroquine; Immunosuppressive Agents; Logistic Models; Lopinavir; Lung Diseases; Lupus Erythematosus, Systemic; Male; Middle Aged; Multivariate Analysis; Pandemics; Pneumonia, Viral; Retrospective Studies; Ritonavir; SARS-CoV-2; Severity of Illness Index; Sex Factors; Spain

2020
Predictive factors for cardiac conduction abnormalities with hydroxychloroquine-containing combinations for COVID-19.
    International journal of antimicrobial agents, 2020, Volume: 56, Issue:4

    Topics: Aged; Anti-Infective Agents; Azithromycin; Betacoronavirus; Biomarkers; Coronavirus Infections; COVID-19; Disease Progression; Drug Combinations; Female; Humans; Hydroxychloroquine; Intensive Care Units; Long QT Syndrome; Lopinavir; Lymphocytes; Male; Middle Aged; Neutrophils; Pandemics; Pneumonia, Viral; Prognosis; Proportional Hazards Models; Retrospective Studies; Ritonavir; SARS-CoV-2; Treatment Outcome; Troponin I

2020
Viral exanthema as manifestation of SARS-CoV-2 infection: A case report.
    Medicine, 2020, Aug-28, Volume: 99, Issue:35

    Topics: Administration, Topical; Adult; Antiviral Agents; Azithromycin; Betacoronavirus; Clinical Laboratory Techniques; Coronavirus Infections; COVID-19; COVID-19 Testing; Drug Combinations; Exanthema; Female; Glucocorticoids; Humans; Hydroxychloroquine; Lopinavir; Pandemics; Pneumonia, Viral; Ritonavir; SARS-CoV-2; Symptom Assessment; Treatment Outcome

2020
Safety assessment of drug combinations used in COVID-19 treatment: in silico toxicogenomic data-mining approach.
    Toxicology and applied pharmacology, 2020, 11-01, Volume: 406

    Topics: Antiviral Agents; Azithromycin; Betacoronavirus; Chloroquine; Computer Simulation; Coronavirus Infections; COVID-19; COVID-19 Drug Treatment; Data Mining; Databases, Genetic; Drug Therapy, Combination; Gene Regulatory Networks; Humans; Hydroxychloroquine; Lopinavir; Pandemics; Pneumonia, Viral; Ritonavir; SARS-CoV-2; Toxicogenetics

2020
Characteristics of COVID-19 clinical trials registered with ClinicalTrials.gov: cross-sectional analysis.
    BMJ open, 2020, 09-17, Volume: 10, Issue:9

    Topics: Antibodies, Monoclonal, Humanized; Antiviral Agents; Azithromycin; Betacoronavirus; Chloroquine; Clinical Trials as Topic; Coronavirus Infections; COVID-19; COVID-19 Drug Treatment; COVID-19 Serotherapy; Double-Blind Method; Drug Combinations; Humans; Hydroxychloroquine; Immunization, Passive; Lopinavir; Pandemics; Pneumonia, Viral; Registries; Ritonavir; SARS-CoV-2; Single-Blind Method; Stem Cell Transplantation

2020
Sex Differences in Reported Adverse Drug Reactions to COVID-19 Drugs in a Global Database of Individual Case Safety Reports.
    Drug safety, 2020, Volume: 43, Issue:12

    Topics: Abdominal Pain; Adenosine Monophosphate; Alanine; Antibodies, Monoclonal, Humanized; Antiviral Agents; Azithromycin; Chemical and Drug Induced Liver Injury; Chloroquine; COVID-19 Drug Treatment; Databases, Pharmaceutical; Diarrhea; Drug Combinations; Drug Eruptions; Drug Repositioning; Drug-Related Side Effects and Adverse Reactions; Female; Humans; Hydroxychloroquine; Long QT Syndrome; Lopinavir; Male; Nausea; Oseltamivir; Ritonavir; Sex Distribution; Sex Factors; Vomiting

2020
Clinical Characteristics and Outcomes of Patients Hospitalized for COVID-19 in Africa: Early Insights from the Democratic Republic of the Congo.
    The American journal of tropical medicine and hygiene, 2020, Volume: 103, Issue:6

    Topics: Adolescent; Adult; Asymptomatic Diseases; Azithromycin; Chloroquine; COVID-19; COVID-19 Drug Treatment; Democratic Republic of the Congo; Drug Combinations; Enoxaparin; Female; Hospital Mortality; Hospitalization; Hospitals; Humans; Intensive Care Units; Lopinavir; Male; Middle Aged; Obesity; Pandemics; Patient Discharge; Renal Insufficiency, Chronic; Retrospective Studies; Risk Factors; Ritonavir; SARS-CoV-2; Severity of Illness Index; Treatment Outcome

2020
Acute aortic dissection in a patient with Williams syndrome infected by COVID-19.
    Cardiology in the young, 2021, Volume: 31, Issue:1

    Topics: Adolescent; Anti-Bacterial Agents; Antiviral Agents; Aortic Aneurysm; Aortic Dissection; Aortic Stenosis, Supravalvular; Aortitis; Azithromycin; COVID-19; COVID-19 Drug Treatment; Drug Combinations; Enzyme Inhibitors; Fatal Outcome; Glucocorticoids; Humans; Hydroxychloroquine; Immunoglobulins, Intravenous; Immunologic Factors; Lopinavir; Male; Methylprednisolone; Oseltamivir; Recurrence; Ritonavir; SARS-CoV-2; Systemic Inflammatory Response Syndrome; Williams Syndrome

2021
Effectiveness of lopinavir/ritonavir on COVID-19-related pneumonia in a child with COVID-19-associated Kawasaki disease.
    Cardiology in the young, 2021, Volume: 31, Issue:3

    Topics: Ampicillin; Anti-Bacterial Agents; Anticoagulants; Antiviral Agents; Azithromycin; Child; COVID-19; COVID-19 Drug Treatment; COVID-19 Nucleic Acid Testing; COVID-19 Serological Testing; Drug Combinations; Enoxaparin; Humans; Hydroxychloroquine; Hypoxia; Immunoglobulins, Intravenous; Immunologic Factors; Lopinavir; Lung; Male; Mucocutaneous Lymph Node Syndrome; Oseltamivir; Oxygen Inhalation Therapy; Ritonavir; Sulbactam; Tomography, X-Ray Computed

2021
Investigational Treatments for COVID-19 may Increase Ventricular Arrhythmia Risk Through Drug Interactions.
    CPT: pharmacometrics & systems pharmacology, 2021, Volume: 10, Issue:2

    Topics: Action Potentials; Antiviral Agents; Arrhythmias, Cardiac; Azithromycin; Chloroquine; COVID-19; COVID-19 Drug Treatment; Drug Combinations; Drug Interactions; Drug Therapy, Combination; Female; Humans; Lopinavir; Male; Models, Theoretical; Myocytes, Cardiac; Risk Factors; Ritonavir; Therapies, Investigational

2021
Prescribing practices of lopinavir/ritonavir, hydroxychloroquine and azithromycin during the COVID-19 epidemic crisis and pharmaceutical interventions in a French teaching hospital.
    European journal of hospital pharmacy : science and practice, 2021, Volume: 28, Issue:5

    Topics: Adult; Aged; Antiviral Agents; Azithromycin; COVID-19 Drug Treatment; Drug Combinations; Drug Prescriptions; Female; France; Hospitals, Teaching; Humans; Hydroxychloroquine; Lopinavir; Male; Middle Aged; Pandemics; Patient Safety; Pharmacists; Physicians; Retrospective Studies; Ritonavir

2021
Use of Intravenous Immunoglobulin (Prevagen or Octagam) for the Treatment of COVID-19: Retrospective Case Series.
    Respiration; international review of thoracic diseases, 2020, Volume: 99, Issue:12

    Topics: Adenosine Monophosphate; Adrenal Cortex Hormones; Adult; Aged; Alanine; Anti-Bacterial Agents; Antibodies, Monoclonal, Humanized; Antiviral Agents; APACHE; Azithromycin; COVID-19; COVID-19 Drug Treatment; Doxycycline; Enzyme Inhibitors; Extracorporeal Membrane Oxygenation; Female; Humans; Hydroxychloroquine; Immunoglobulins, Intravenous; Immunologic Factors; Intensive Care Units; Length of Stay; Lopinavir; Male; Middle Aged; Respiration, Artificial; Retrospective Studies; Severity of Illness Index; Time Factors; Young Adult

2020
Can we use hydroxychloroquine to treat COVID-19 now?
    International journal of antimicrobial agents, 2021, Volume: 57, Issue:1

    Topics: Anti-Bacterial Agents; Antimalarials; Antiviral Agents; Azithromycin; Clinical Trials as Topic; COVID-19; COVID-19 Drug Treatment; Drug Combinations; Drug Repositioning; Humans; Hydroxychloroquine; Indoles; Interferon-alpha; Lopinavir; Ritonavir; SARS-CoV-2; Uncertainty

2021
Azithromycin, a questionable treatment for COVID-19.
    International journal of antimicrobial agents, 2021, Volume: 57, Issue:3

    Topics: Azithromycin; COVID-19 Drug Treatment; Drug Combinations; Drug Therapy, Combination; Humans; Hydroxychloroquine; Lopinavir; Methylprednisolone; Ritonavir; SARS-CoV-2

2021
Molecular Docking of Azithromycin, Ritonavir, Lopinavir, Oseltamivir, Ivermectin and Heparin Interacting with Coronavirus Disease 2019 Main and Severe Acute Respiratory Syndrome Coronavirus-2 3C-Like Proteases.
    Journal of nanoscience and nanotechnology, 2021, 04-01, Volume: 21, Issue:4

    Topics: Azithromycin; Coronavirus 3C Proteases; COVID-19; Heparin; Humans; Ivermectin; Lopinavir; Molecular Docking Simulation; Oseltamivir; Ritonavir; SARS-CoV-2

2021
Simultaneous quantification of seven repurposed COVID-19 drugs remdesivir (plus metabolite GS-441524), chloroquine, hydroxychloroquine, lopinavir, ritonavir, favipiravir and azithromycin by a two-dimensional isotope dilution LC-MS/MS method in human serum
    Journal of pharmaceutical and biomedical analysis, 2021, Mar-20, Volume: 196

    Topics: Adenosine; Adenosine Monophosphate; Alanine; Amides; Antiviral Agents; Azithromycin; Chloroquine; Chromatography, Liquid; COVID-19; COVID-19 Drug Treatment; Furans; Humans; Hydroxychloroquine; Isotopes; Lopinavir; Pandemics; Pyrazines; Pyrroles; Ritonavir; SARS-CoV-2; Tandem Mass Spectrometry; Triazines

2021
Different incidences of acute kidney injury (AKI) and outcomes in COVID-19 patients with and without non-azithromycin antibiotics: A retrospective study.
    Journal of medical virology, 2021, Volume: 93, Issue:7

    Topics: Acute Kidney Injury; Adult; Angiotensin-Converting Enzyme Inhibitors; Antiviral Agents; Azithromycin; Coinfection; COVID-19; COVID-19 Drug Treatment; Critical Care; Drug Combinations; Female; Hospital Mortality; Hospitalization; Humans; Iran; Linezolid; Lopinavir; Male; Middle Aged; Retrospective Studies; Ribavirin; Ritonavir; SARS-CoV-2; Treatment Outcome; Vancomycin

2021
Use of repurposed and adjuvant drugs in hospital patients with covid-19: multinational network cohort study.
    BMJ (Clinical research ed.), 2021, 05-11, Volume: 373

    Topics: Administrative Claims, Healthcare; Adolescent; Adrenal Cortex Hormones; Adult; Aged; Aged, 80 and over; Azithromycin; Ceftriaxone; Chemotherapy, Adjuvant; Child; Child, Preschool; China; Cohort Studies; COVID-19; COVID-19 Drug Treatment; Drug Combinations; Drug Repositioning; Electronic Health Records; Enoxaparin; Female; Fluoroquinolones; Humans; Hydroxychloroquine; Infant; Infant, Newborn; Inpatients; Lopinavir; Male; Middle Aged; Republic of Korea; Ritonavir; Safety; SARS-CoV-2; Spain; Treatment Outcome; United States; Vitamin D; Young Adult

2021
QT Interval Monitoring with Handheld Heart Rhythm ECG Device in COVID-19 Patients.
    Global heart, 2021, 06-08, Volume: 16, Issue:1

    Topics: Aged; Aged, 80 and over; Anti-Bacterial Agents; Antiviral Agents; Azithromycin; COVID-19 Drug Treatment; Drug Combinations; Electrocardiography; Enzyme Inhibitors; Feasibility Studies; Female; Humans; Hydroxychloroquine; Long QT Syndrome; Lopinavir; Male; Middle Aged; Point-of-Care Systems; Prospective Studies; Reproducibility of Results; Ritonavir; SARS-CoV-2

2021
Comparison of demographic and clinical characteristics of hospitalized COVID-19 patients with severe/critical illness in the first wave versus the second wave.
    Journal of medical virology, 2022, Volume: 94, Issue:1

    Topics: Aged; Amides; Antibodies, Monoclonal, Humanized; Azithromycin; C-Reactive Protein; Comorbidity; COVID-19; COVID-19 Drug Treatment; Critical Care; Drug Combinations; Enoxaparin; Female; Hospital Mortality; Hospitalization; Humans; Hydroxychloroquine; Interleukin 1 Receptor Antagonist Protein; Lopinavir; Male; Methylprednisolone; Middle Aged; Pyrazines; Retrospective Studies; Ritonavir; SARS-CoV-2; Severity of Illness Index; Treatment Outcome; Turkey

2022
The Challenging Anticoagulant Therapy in COVID19 Patient with Associated Coagulopathy.
    Acta medica Indonesiana, 2021, Volume: 53, Issue:3

    Topics: Adult; Antiviral Agents; Azithromycin; Clinical Deterioration; COVID-19; COVID-19 Drug Treatment; Dose-Response Relationship, Drug; Drug Monitoring; Factor Xa Inhibitors; Fibrin Fibrinogen Degradation Products; Fondaparinux; Hemorrhage; Humans; Inosine Pranobex; Lopinavir; Male; Pulmonary Embolism; SARS-CoV-2; Thrombophilia; Treatment Outcome

2021
Off-Label Use of Hydroxychloroquine in COVID-19: Analysis of Reports of Suspected Adverse Reactions From the Italian National Network of Pharmacovigilance.
    Journal of clinical pharmacology, 2022, Volume: 62, Issue:5

    Topics: Azithromycin; COVID-19 Drug Treatment; Diarrhea; Drug-Related Side Effects and Adverse Reactions; Humans; Hydroxychloroquine; Long QT Syndrome; Lopinavir; Off-Label Use; Pharmacovigilance; Ritonavir

2022
High-cited favorable studies for COVID-19 treatments ineffective in large trials.
    Journal of clinical epidemiology, 2022, Volume: 148

    Topics: Azithromycin; Colchicine; COVID-19 Drug Treatment; COVID-19 Serotherapy; Humans; Hydroxychloroquine; Interferons; Lopinavir; Ritonavir

2022
Use of combined treatment of 3rd-generation cephalosporin, azithromycin and antiviral agents on moderate SARs-CoV-2 patients in South Korea: A retrospective cohort study.
    PloS one, 2022, Volume: 17, Issue:5

    Topics: Anti-Bacterial Agents; Antiviral Agents; Azithromycin; Cephalosporins; COVID-19 Drug Treatment; Humans; Hydroxychloroquine; Lopinavir; Retrospective Studies; Ritonavir; SARS-CoV-2; Treatment Outcome

2022